Deleterious alterations of DNA damage response and repair (DDR) genes in association with clinical benefit to programmed cell death protein-1 (PD-1)/PD ligand 1 (PD-L1)-based therapy in esophageal squamous cell carcinoma (ESCC)

被引：0
|
作者：
Guo, Jhe-Cyuan
Lin, Chia-Chi
Huang, Ta-Chen
Chang, Chun-Jung
Kuo, Hung-Yang
Hsu, Chih-Hung
机构：
[1] Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Taipei, Taiwan
[4] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
28
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Activated interferon-γ (IFN-γ) pathway associated with clinical benefit to programmed cell death protein-1 (PD-1)/PD ligand 1 (PD-L1)-based therapy in esophageal squamous cell carcinoma (ESCC).
    Guo, Jhe-Cyuan
    Hsieh, Min-Shu
    Lin, Chia-Chi
    Huang, Ta-Chen
    Chang, Chun-Jung
    Hsu, Chih-Hung
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [2] Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma
    Jhe-Cyuan Guo
    Chia-Chi Lin
    Chia-Lang Hsu
    Ta-Chen Huang
    Hung-Yang Kuo
    Chen-Yuan Lin
    Ming-Yu Lien
    Ann-Lii Cheng
    Chih-Hung Hsu
    Esophagus, 2022, 19 : 693 - 701
  • [3] Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma
    Guo, Jhe-Cyuan
    Lin, Chia-Chi
    Hsu, Chia-Lang
    Huang, Ta-Chen
    Kuo, Hung-Yang
    Lin, Chen-Yuan
    Lien, Ming-Yu
    Cheng, Ann-Lii
    Hsu, Chih-Hung
    ESOPHAGUS, 2022, 19 (04) : 693 - 701
  • [4] Association of B cells in tumor microenvironment (TME) with clinical benefit to programmed cell death protein-1 (PD-1) blockade therapy in esophageal squamous cell carcinoma (ESCC).
    Guo, Jhe-Cyuan
    Hsu, Chia-Lang
    Huang, Yen-Lin
    Lin, Chia-Chi
    Huang, Ta-Chen
    Chang, Chun-Jung
    Kuo, Hung-Yang
    Hsu, Chih-Hung
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [5] Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives
    Mocan, T.
    Sparchez, Z.
    Craciun, R.
    Bora, C. N.
    Leucuta, D. C.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (06): : 702 - 712
  • [6] Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives
    T. Mocan
    Z. Sparchez
    R. Craciun
    C. N. Bora
    D. C. Leucuta
    Clinical and Translational Oncology, 2019, 21 : 702 - 712
  • [7] Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
    Tatiana Salles de Souza Malaspina
    Thaís Helena Gasparoto
    Maria Renata Sales Nogueira Costa
    Edgard Franco de Melo
    Maura Rosane Valério Ikoma
    José Humberto Damante
    Karen Angélica Cavassani
    Gustavo Pompermaier Garlet
    João Santana da Silva
    Ana Paula Campanelli
    Cancer Immunology, Immunotherapy, 2011, 60 : 965 - 974
  • [8] Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
    de Souza Malaspina, Tatiana Salles
    Gasparoto, Thais Helena
    Sales Nogueira Costa, Maria Renata
    de Melo, Edgard Franco, Jr.
    Valerio Ikoma, Maura Rosane
    Damante, Jose Humberto
    Cavassani, Karen Angelica
    Garlet, Gustavo Pompermaier
    da Silva, Joao Santana
    Campanelli, Ana Paula
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (07) : 965 - 974
  • [9] In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)
    Reddy, Vishwanatha R. A. P.
    Mwangi, William
    Sadigh, Yashar
    Nair, Venugopal
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
  • [10] Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics
    Abaza, Abdelrahman
    Idris, Faten Sid
    Shaikh, Humna Anis
    Vahora, Ilma
    Moparthi, Kiran Prasad
    Al Rushaidi, Majdah T.
    Muddam, Meghana Reddy
    Obajeun, Omobolanle A.
    Jaramillo, Arturo P.
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
12345